Doctors warned over NOACs in antiphospholipid syndrome

There is increased risk of thrombotic events with the drugs in some patients, warns TGA

Regulators are warning about the use of non-vitamin K antagonist oral anticoagulants in patients with antiphospholipid syndrome.